Symbol
Anika Therapeutics Inc.
Full name of the company.
MEDICAL-BIOMED/GENETICS
Industry name
DRUGS
Major industry name
Medical
Sector name
$13.96
Current price of the stock
$90K
Trading volume of the stock
$206.2M
Market capitalization of the company
Micro Cap
Category of market capitalization
10.00%
Long-term growth mean estimate
5.00
Mean analyst rating
43.27%
Potential price appreciation based on analyst price targets
-
Percentage difference of EPS surprise
-
Dividend change over 1 year
$0.00
Shows the amount of dividend paid
-
Total debt to total equity ratio
5.34
Current ratio
3.72%
Gross profit margin
-72.30%
Operating profit margin
-72.30%
Earnings before interest and taxes (EBIT) margin
-
Earnings before interest, taxes, depreciation, and amortization (EBITDA) margin
-71.25%
Pretax profit margin
-77.20%
Net profit margin
-16.63%
Measures profitability relative to shareholders' equity
-17.69%
ROE excluding intangible assets
-12.93%
Measures profitability relative to total assets
-16.63%
Measures profitability relative to invested capital
0.17
Asset turnover ratio
0.94
Inventory turnover ratio
1.37
Receivables turnover ratio
65.86
Average number of days it takes to collect receivables
-2.10
Measures valuation relative to earnings
-24.49
P/E based on future earnings estimates
1.26
Measures valuation relative to sales
1.14
Measures valuation relative to book value
293.28
Measures valuation relative to operating cash flow
-11.33
Measures valuation relative to free cash flow
0
Indicates company's M&A activity
© 2022 - 2025 QuantStrategy.io, Arizet Labs, LLC
